Literature DB >> 34622303

[Treatment recommendations for early esophageal cancer : Endoscopic and surgical options].

T Schlosser1, A Hoffmeister1, J Feisthammel1, S Niebisch2, R Thieme2, I Gockel3.   

Abstract

BACKGROUND: Esophageal cancer represents a complex tumor entity with an increasing proportion of adenocarcinomas. Early esophageal cancer is staged as m1-m3 depending on the depth of infiltration into the mucosa and as sm1-sm3 depending on invasion into the submucosa. The risk of lymph node metastasis is strongly correlated with the depth of invasion and increases by leaps and bounds with submucosal infiltration.
MATERIAL AND METHODS: This review is based on publications retrieved by a selective database search (MEDLINE, PubMed, Cochrane Library, International Standard Randomised Controlled Trial Number, ISRCTN, registry) on the current management of early esophageal cancer.
RESULTS: The endoscopic diagnostics and evaluation of the dignity of superficial esophageal cancer by traditional staining techniques have been expanded by virtual chromoendoscopy. Endoscopic resection is the diagnostic and therapeutic procedure of choice for mucosal low risk adenocarcinomas (grade 1 or 2, no blood or lymph vessel invasion). Under certain prerequisites adenocarcinomas of the upper submucosa (sm1) can also be endoscopically removed. All other stages necessitate surgical treatment. In squamous cell carcinoma without risk factors a surgical oncological esophageal resection is indicated after infiltration of the third mucosal layer (m3). Endoscopic submucosal dissection (ESD) shows high rates of en bloc and R0 (curative) resections even with large lesions.
CONCLUSION: Borderline cases between endoscopic and surgical treatment of early esophageal cancer necessitate an interdisciplinary approach and individually adapted management, which in the locally advanced stage are always embedded in a multimodal concept.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Endoscopic mucosal resection; Endoscopic submucosal dissection; Esophagectomy; Superficial esophageal neoplasm; Surgical treatment

Mesh:

Year:  2021        PMID: 34622303     DOI: 10.1007/s00104-021-01513-7

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  43 in total

Review 1.  Staining in gastrointestinal endoscopy: the basics.

Authors:  M I Canto
Journal:  Endoscopy       Date:  1999-08       Impact factor: 10.093

2.  Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract.

Authors:  Y Cao; C Liao; A Tan; Y Gao; Z Mo; F Gao
Journal:  Endoscopy       Date:  2009-08-19       Impact factor: 10.093

3.  The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients.

Authors:  Yasunori Akutsu; Masaya Uesato; Kiyohiko Shuto; Tsuguaki Kono; Isamu Hoshino; Daisuke Horibe; Testutaro Sazuka; Nobuyoshi Takeshita; Tetsuro Maruyama; Yuka Isozaki; Naoki Akanuma; Hisahiro Matsubara
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

4.  Long-term follow-up after endoscopic resection for superficial esophageal squamous cell carcinoma: a multicenter Western study.

Authors:  Arthur Berger; Gabriel Rahmi; Guillaume Perrod; Mathieu Pioche; Jean-Marc Canard; Elodie Cesbron-Métivier; Jérôme Boursier; Elia Samaha; Ariane Vienne; Vincent Lépilliez; Christophe Cellier
Journal:  Endoscopy       Date:  2018-09-27       Impact factor: 10.093

5.  [Respiration].

Authors:  T Nishiyama
Journal:  Kango Kyoshitsu       Date:  1974-09

Review 6.  The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.

Authors:  Kerry B Dunbar; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2012-06       Impact factor: 10.864

Review 7.  Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.

Authors:  Matthew F Buas; Thomas L Vaughan
Journal:  Semin Radiat Oncol       Date:  2013-01       Impact factor: 5.934

8.  A global assessment of the oesophageal adenocarcinoma epidemic.

Authors:  Gustaf Edgren; Hans-Olov Adami; Elisabete Weiderpass; Elisabete Weiderpass Vainio; Olof Nyrén
Journal:  Gut       Date:  2012-08-23       Impact factor: 23.059

9.  Prediction of lymph node status in superficial esophageal carcinoma.

Authors:  Ermanno Ancona; Sabrina Rampado; Mauro Cassaro; Giorgio Battaglia; Alberto Ruol; Carlo Castoro; Giuseppe Portale; Francesco Cavallin; Massimo Rugge
Journal:  Ann Surg Oncol       Date:  2008-08-26       Impact factor: 5.344

Review 10.  Diagnosis and treatment of superficial esophageal cancer.

Authors:  Maximilien Barret; Frédéric Prat
Journal:  Ann Gastroenterol       Date:  2018-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.